tradingkey.logo

Integer Holdings Corp

ITGR
View Detailed Chart
86.450USD
+1.220+1.43%
Close 02/06, 16:00ETQuotes delayed by 15 min
3.03BMarket Cap
34.12P/E TTM

Integer Holdings Corp

86.450
+1.220+1.43%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.43%

5 Days

-0.47%

1 Month

+6.98%

6 Months

-17.95%

Year to Date

+10.23%

1 Year

-38.65%

View Detailed Chart

Key Insights

Integer Holdings Corp's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 64 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 85.57.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Integer Holdings Corp's Score

Industry at a Glance

Industry Ranking
64 / 205
Overall Ranking
173 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Integer Holdings Corp Highlights

StrengthsRisks
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 28.94% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.72B.
Undervalued
The company’s latest PE is 34.12, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 39.35M shares, decreasing 11.04% quarter-over-quarter.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 211.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.25.

Analyst Rating

Based on 11 analysts
Hold
Current Rating
85.571
Target Price
+0.40%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Integer Holdings Corp News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Integer Holdings Corp Info

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
Ticker SymbolITGR
CompanyInteger Holdings Corp
CEOKhales (Payman)
Websitehttps://www.integer.net/home/default.aspx
KeyAI